
P/E Ratio: Price to Earnings - Most used valuation metric
Analyzing Investment Quality
Processing 9 key metrics...
Standalone • Annual • All amounts in ₹ Crores • CA Schedule III Format
Standalone annual data is not available for this symbol.
Try switching to Consolidated view.
Loading shareholding data...
| Insider Name | Transaction Date | Filing Date | Total Shares | Change | Price | Action |
|---|---|---|---|---|---|---|
Eskay Infrastructure Development Private Limited | 19 Feb 2025 | 20 Feb 2025 | 10.60 L | 14,304 | ₹284.52 | BUY |
Eskay Infrastructure Development Private Limited | 24 Feb 2025 | 26 Feb 2025 | 10.65 L | 5,000 | ₹280 | BUY |
Paripurna Trust | 19 Mar 2025 | 21 Mar 2025 | 8.71 L | 1.00 L | - | BUY |
Anupma Khetan | 19 Mar 2025 | 21 Mar 2025 | - | 1.00 L | - | SELL |
SW Capital Private Limited | 04 Jun 2025 | 06 Jun 2025 | 10.22 L | 450 | ₹283.84 | BUY |
SW Capital Private Limited | 09 Jun 2025 | 10 Jun 2025 | 10.23 L | 1,101 | ₹283.98 | BUY |
SW Capital Private Limited | 12 Jun 2025 | 13 Jun 2025 | 10.23 L | 122 | ₹284 | BUY |
Standard pivot points - most widely used
| Level | Price | Distance | % Change |
|---|---|---|---|
| R4 | ₹289.43 | +₹28.63 | +10.98% |
| R3 | ₹278.63 | +₹17.83 | +6.84% |
| R2 | ₹274.87 | +₹14.07 | +5.39% |
| R1 | ₹267.83 | +₹7.03 | +2.70% |
| PIVOT | ₹264.07 | 3.27 | 1.25% |
| CURRENT | ₹260.80 | - | - |
| S1 | ₹235.43 | -₹25.37 | -9.73% |
| S2 | ₹246.23 | -₹14.57 | -5.59% |
| S3 | ₹253.27 | -₹7.53 | -2.89% |
| S4 | ₹257.03 | -₹3.77 | -1.44% |
is trading CPR, indicating
CPR is
Day's range: ~
Trading Inside opening range
| Company Name |
|---|
Baid Finserv Ltd |
CSL Finance Ltd |
Indian Railway Finance Corporation Ltd |
Mufin Green Finance Ltd |
Vardhman Holdings Ltd |

Starteck Finance Limited is a non-banking financial company (NBFC) operating within India's financial sector. Unlike traditional banks, it doesn't accept deposits from the public. Instead, it focuses on providing various financing solutions to a diverse customer base.
The company's clientele is broadly categorized into three segments: retail customers, small and medium enterprises (SMEs), and commercial customers. This diversification allows Starteck to cater to a wide range of financial needs, from individual personal loans to larger-scale business financing.
Starteck's geographical reach extends across both urban and semi-urban areas of India, indicating a commitment to serving a broad spectrum of the Indian population. This expansion beyond major metropolitan centers suggests a strategic focus on reaching underserved markets and contributing to financial inclusion.
The company's history traces back to 1985, when it was founded under the name Nivedita Mercantile and Financing Limited. A significant rebranding occurred in November 2018, with the adoption of the current name, Starteck Finance Limited. This change likely reflects a strategic shift or a desire to enhance its brand image and market presence.
Headquartered in Mumbai, India, Starteck Finance Limited benefits from being located in a major financial hub. This location provides access to a wider pool of resources, talent, and networking opportunities, enhancing its operational capabilities and market competitiveness within the Indian NBFC sector.
5th Floor, Sunteck Centre, 37-40, Subhash Road, Vileparle (E)
Mumbai
MAHARASHTRA
IN
Tel: 912242877800
Website:http://www.starteckfinance.com/
Group: Financial Services
Sector: Financials
Industry: Financial Services
Exchange: NATIONAL STOCK EXCHANGE OF INDIA
Employees: 5
IPO Date: 18/03/2008
Mr. Amit Pitale
Chief Financial Officer, Whole Time Director
Mr. Laukik Bhise
Company Secretary and Compliance Officer
Mr. Pankaj Jain
Non-Executive Non-Independent Director
Mr. Anand Shroff
Non-Executive Non-Independent Director
Mrs. Sandhya Malhotra
Non-Executive Independent Director
Mr. Gautam Panchal
Non-Executive Independent Director
Mr. Nilesh Parikh
Additional Non-Executive Independent Director
Get answers to the most common questions about Starteck Finance Ltd stock price, fundamentals, financial metrics, and investment analysis